Trial Profile
A retrospective study evaluating postoperative complications in a cohort of Crohn's disease and Ulcerative colitis paediatric patients treated with vedolizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2018
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions
- 02 Nov 2018 New trial record